- Directory
- August 2026
Global
From €1748EUR$1,950USD£1,499GBP
- Newsletter
- August 2026
Global
€2684EUR$2,995USD£2,303GBP
- Report
- February 2026
- 130 Pages
Global
From €4347EUR$4,850USD£3,729GBP
- Report
- December 2025
- 36 Pages
Global
From €2644EUR$2,950USD£2,268GBP
- Report
- November 2025
- 135 Pages
Global
From €4347EUR$4,850USD£3,729GBP
- Report
- October 2025
- 80 Pages
Global
From €4033EUR$4,500USD£3,460GBP
- Report
- October 2025
- 89 Pages
Global
From €4033EUR$4,500USD£3,460GBP
- Report
- August 2025
- 115 Pages
Global
From €3092EUR$3,450USD£2,653GBP
- Report
- April 2026
Middle East, Africa
From €4301EUR$4,799USD£3,690GBP
- Report
- September 2025
- 150 Pages
Middle East
From €4436EUR$4,950USD£3,806GBP
- Report
- September 2025
- 150 Pages
United States
From €5332EUR$5,950USD£4,575GBP
- Report
- October 2025
- 150 Pages
Middle East
From €5332EUR$5,950USD£4,575GBP
- Report
- September 2025
- 85 Pages
United States
From €3137EUR$3,500USD£2,691GBP
- Report
- June 2026
- 90 Pages
Asia Pacific
From €4257EUR$4,750USD£3,652GBP
- Report
- May 2026
- 102 Pages
Middle East
From €3540EUR$3,950USD£3,037GBP
- Report
- October 2025
- 87 Pages
United States
From €4033EUR$4,500USD£3,460GBP
- Report
- October 2025
- 98 Pages
Middle East
From €4033EUR$4,500USD£3,460GBP
- Report
- August 2025
- 80 Pages
Middle East, Africa
From €3092EUR$3,450USD£2,653GBP
- Report
- August 2025
- 98 Pages
Asia Pacific
From €3540EUR$3,950USD£3,037GBP
- Report
- August 2025
- 101 Pages
Europe
From €3540EUR$3,950USD£3,037GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more